RT @drbobphillips: We then jump in quick and give powerful, otherwise restricted use antibiotics, in case there’s a very bad bug. If there…
RT @drbobphillips: We then jump in quick and give powerful, otherwise restricted use antibiotics, in case there’s a very bad bug. If there…
We then jump in quick and give powerful, otherwise restricted use antibiotics, in case there’s a very bad bug. If there is, quicker is probably better. We’ve looked to see how people can speed it up … (2/7) https://t.co/7MFYpf6dz6
RT @CancerCareMASCC: This review may help centers identify patients by their specific sources of delay and barriers to change and to define…
This review may help centers identify patients by their specific sources of delay and barriers to change and to define what intervention may be best to apply to antibiotics (TTA) with fever and neutropenia (FN) following chemotherapy for cancer. Thoughts?
RT @VCCLibrary: Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and #neutropenia during chemotherapy for ca…
Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and #neutropenia during chemotherapy for cancer (FN), a systematic review https://t.co/3aqzAiUcmZ #cancer
RT @drbobphillips: Anyone who's currently looking to have an evidence-base for their QI project in time-to-antibiotics could spend a few mo…
RT @drbobphillips: Anyone who's currently looking to have an evidence-base for their QI project in time-to-antibiotics could spend a few mo…
RT @drbobphillips: Anyone who's currently looking to have an evidence-base for their QI project in time-to-antibiotics could spend a few mo…
Anyone who's currently looking to have an evidence-base for their QI project in time-to-antibiotics could spend a few moments looking at this systematic review https://t.co/8IHSvtBgCe from @christa_koenig @drjessmorgan and me among others @crd_york